| Gene symbol | AFP | Synonyms | AFPD, FETA, HPAFP | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | alpha fetoprotein | ||||
| GTO ID | GTC2078 |
| Trial ID | NCT03888859 |
| Disease | Metastatic Liver Cancer | Hepatocellular Carcinoma | Liver Cancer |
| Altered gene | AFP |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | ET1402L1-ARTEMIS T cells |
| HLA | HLA-A*02 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase 1, Open-label, Three Routes IV, Intratumoral Injections and Intra-hepatic Artery Dose-escalation Clinical Study to Evaluate the Safety and Efficacy of ET1402L1-ARTEMIS2 T- Cells in AFP Expressing Hepatocellular Carcinoma (HCC) |
| Year | 2019 |
| Country | China |
| Company sponsor | First Affiliated Hospital Xi'an Jiaotong University |
| Other ID(s) | XJTU1AF2017LSL-C002 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||